Approval · Notice of Compliance 31647 · 2023

ZELDOX: Notice of Compliance 31647

Issued September 15, 2023

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 31647
Date: September 15, 2023
Company: BGP Pharma ULCEtobicoke, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Administrative: Change in Product Ownership

Products in this notice

Brand	DIN	Status today
ZELDOX	02298597	Marketed
ZELDOX	02298600	Marketed
ZELDOX	02298619	Marketed
ZELDOX	02298627	Marketed

Medicinal ingredients

ZIPRASIDONE 20 MG per CAP
ZIPRASIDONE 40 MG per CAP
ZIPRASIDONE 60 MG per CAP
ZIPRASIDONE 80 MG per CAP